May 22, 2025, 23:03

MRC Infections and Immunity – Research Grant

The Medical Research Council (MRC) invites applications for research projects that advance the understanding of infectious diseases, immunity, inflammation, and immune-mediated conditions. This opportunity supports innovative and impactful research with the potential to improve human health through discoveries in immunology, infectious disease biology, and host-pathogen interactions.

Eligibility Criteria:

Applicant must be employed by a UK-based organisation eligible for MRC funding
Must lead and be actively engaged in the proposed work
International researchers can participate as project co-leads (international)
Project must focus on infections and immunity
Collaborations with MRC Units in The Gambia or Uganda are eligible to lead

Research Areas Supported:

Human pathogens (bacterial, viral, fungal, parasitic)
Immunology and inflammation
Immune-mediated diseases and multimorbidity
Vaccinology and vaccine development
Antimicrobial resistance
Biomarkers, diagnostics, and therapeutics
Co-infection and chronic infection
Epidemiology and transmission

Funding Details:

No cap on budget; must be appropriate and justified
80% of full economic cost (FEC) covered by MRC
100% of permitted exceptions and costs for DAC-listed international collaborators
Co-leads from high-income countries, India, and China may request up to 30% of total project cost
Eligible costs include salaries, staff support, equipment, consumables, travel, data management, and public engagement

Project Duration:

Up to 5 years (typical projects last 3–4 years)
Short projects (<2 years) must justify proof-of-concept/high-risk focus
Project start expected 1–6 months after funding decision

Deadline:

4 September 2025 at 4:00 PM UK time

Where to Go for Further Information:

Official Page: https://www.ukri.org/opportunity/infections-and-immunity-research-grant

Scientific Queries: [email protected]

Technical Support: [email protected]

antimicrobial resistance biomarkers cancer co-infection Diagnostics epidemiology host-pathogen immune disorders immunology infectious diseases inflammation mrc research grant OncoDaily Oncology public health Therapeutics vaccines

Inside ASCO25 Exhibition - Who did it the best?

Douglas Flora: Fighting Cancer with Heart

Eric Small: Deeply Honored to Step Into the Role of 2025-26 ASCO President

Cyril Konto: I Trademarked The Word ‘Multispecific’ The Day I Arrived

Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart